Literature DB >> 7494247

Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection.

M B Oldstone1, H Lewicki, P Borrow, D Hudrisier, J E Gairin.   

Abstract

Structural characterization of peptides restricted by major histocompatibility complex (MHC) class I molecules has identified residues critical for MHC class I binding and for T-cell receptor recognition. For example, optimal peptides fitting into the murine MHC class I Db groove are 9 to 11 amino acids long and require as MHC anchor residues an Asn (N) at position 5 and also either a hydrophobic residue, a Met (M) or a Cys (C), at the carboxy terminus. The three known Db-restricted peptides of lymphocytic choriomeningitis virus (LCMV) are glycoproteins GP1 (amino acids [aa] 33 KAVYNFATC), GP2 (aa 276 SGVENPGGYCL), and nucleoprotein NP (aa 396 FQPQNGQFI). In addition to these two GP and one NP peptides, computer search revealed 11 other GP peptide sequences and 20 additional NP sequences that contained the Db binding motif. By Db competitive binding analysis, only two of these 11 GP peptides and 1 of these 20 NP peptides bound to the MHC Db molecule with an affinity equivalent to the measured affinities for the three known GP1, GP2, and NP cytotoxic T-lymphocyte (CTL) epitopes. No CTL specific for these three peptides were generated when H-2b mice were inoculated with viral variants in which either the two known GP epitopes (GP1 and GP2; termed GPV) or the GPV and NP epitopes (termed GPV + NPV) were mutated. However, a novel CD8+ anti-LCMV CTL response ordinarily not seen in H-2b mice inoculated with wild-type virus was noted when such mice were inoculated with the GPV + NPV-mutated variant. This result indicates that (i) despite large numbers of peptides containing the appropriate anchor residues within a viral protein, only a restricted number induce CTL, thereby maintaining a limited CTL repertoire, (ii) despite the limited repertoire, the immune system retains the flexibility to generate an immune response(s) to a previously silent protein(s), suggesting a hierarchial control mechanism, and (iii) identification of a primary amino acid sequence is not sufficient, per se, to predict CTL epitopes, and peptide conformations are likely more complex than indicated by simple linear sequence comparisons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494247      PMCID: PMC189679     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

2.  Temporal analysis of transcription and replication during acute infection with lymphocytic choriomeningitis virus.

Authors:  F V Fuller-Pace; P J Southern
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

3.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. V. Recognition is restricted to gene products encoded by the viral S RNA segment.

Authors:  Y Riviere; P J Southern; R Ahmed; M B Oldstone
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

4.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

5.  Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses.

Authors:  M J Buchmeier; H A Lewicki; O Tomori; M B Oldstone
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

6.  The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2.

Authors:  Y Riviere; R Ahmed; P J Southern; M J Buchmeier; F J Dutko; M B Oldstone
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

7.  Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus.

Authors:  J L Whitton; P J Southern; M B Oldstone
Journal:  Virology       Date:  1988-02       Impact factor: 3.616

8.  Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-).

Authors:  M Salvato; E Shimomaye; P Southern; M B Oldstone
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

9.  Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes.

Authors:  J L Whitton; M B Oldstone
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.

Authors:  M B Oldstone; J L Whitton; H Lewicki; A Tishon
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  11 in total

1.  Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus.

Authors:  D Hudrisier; J Riond; J E Gairin
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease.

Authors:  Sanda Remakus; Daniel Rubio; Xueying Ma; Alessandro Sette; Luis J Sigal
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

3.  Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization.

Authors:  T M Fu; A Friedman; J B Ulmer; M A Liu; J J Donnelly
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.

Authors:  T M Fu; L M Mylin; T D Schell; I Bacik; G Russ; J W Yewdell; J R Bennink; S S Tevethia
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection.

Authors:  S Vijh; I M Pilip; E G Pamer
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

6.  Anti-IFN-γ and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cells.

Authors:  Myriam F Wlodarczyk; Anke R Kraft; Hong D Chen; Laurie L Kenney; Liisa K Selin
Journal:  J Immunol       Date:  2013-02-13       Impact factor: 5.422

Review 7.  Virus-induced autoimmune disease.

Authors:  M G von Herrath; M B Oldstone
Journal:  Curr Opin Immunol       Date:  1996-12       Impact factor: 7.486

8.  Broad-Based Influenza-Specific CD8+ T Cell Response without the Typical Immunodominance Hierarchy and Its Potential Implication.

Authors:  Miaojuan Huang; Rong Xu; Cristina Triffon; Nicole Mifsud; Weisan Chen
Journal:  Viruses       Date:  2021-06-05       Impact factor: 5.048

9.  2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes.

Authors:  Elizabeth M Kolawole; Rakieb Andargachew; Baoyu Liu; Jesica R Jacobs; Brian D Evavold
Journal:  Front Immunol       Date:  2018-10-15       Impact factor: 7.561

Review 10.  Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?

Authors:  P Borrow; G M Shaw
Journal:  Immunol Rev       Date:  1998-08       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.